Fingerprint
Dive into the research topics of 'Phase II study of cisplatin plus etoposide and bevacizumab for previously untreated, extensive-stage small-cell lung cancer: Eastern cooperative oncology group study E3501'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically